| Serial Number | 98501127 |
| Word Mark | GIANTCR |
| Filing Date | Monday, April 15, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, February 18, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 18, 2025 |
| Pseudo Mark | GIAN TCR; GIANT CR; GIANT TCR; GIANT T CELL RECEPTOR |
| Goods and Services | Culturing of cells for scientific research purposes; Cell culture services for scientific and research purposes, for others; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Pharmaceutical research and development; Research and development in the field of pharmaceuticals for the pharmaceutical industry; Research and development in the field of biotechnology; Research and development in the field of diagnostic preparations; Research and development in the field of microorganisms and cells; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research and development services in the field of immunology; Advisory services relating to scientific research; Biochemical research and development; Biomedical research services; Biotechnology research; Chemical research and analysis; Clinical research in the fields of viral disease, cancer, and cell therapy; Consultancy in the field of pharmaceutical research; Consultancy relating to pharmaceutical research and development; Gene therapy research; Laboratory research services relating to pharmaceuticals; Medical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Stem cell research; Advisory services relating to gene therapy research |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SCG Cell Therapy Pte Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | Singapore 109683 SG |
| Party Name | SCG Cell Therapy Pte Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | Singapore 109683 SG |
| Event Date | Event Description |
| Tuesday, October 29, 2024 | ASSIGNED TO EXAMINER |
| Monday, April 15, 2024 | NEW APPLICATION ENTERED |
| Friday, September 27, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 4, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, November 4, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, November 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 23, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 23, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 23, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 12, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 18, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 18, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |